Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.… Read more
Myomo Inc (MYO) - Total Assets
Latest total assets as of September 2025: $34.08 Million USD
Based on the latest financial reports, Myomo Inc (MYO) holds total assets worth $34.08 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Myomo Inc - Total Assets Trend (2014–2024)
This chart illustrates how Myomo Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Myomo Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Myomo Inc's total assets of $34.08 Million consist of 77.6% current assets and 22.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $24.37 Million | 57.7% |
| Accounts Receivable | $3.83 Million | 9.1% |
| Inventory | $3.17 Million | 7.5% |
| Property, Plant & Equipment | $8.91 Million | 21.1% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Myomo Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Myomo Inc's current assets represent 77.6% of total assets in 2024, a decrease from 94.5% in 2014.
- Cash Position: Cash and equivalents constituted 57.7% of total assets in 2024, down from 79.6% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is cash and equivalents at 57.7% of total assets.
Myomo Inc Competitors by Total Assets
Key competitors of Myomo Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Myomo Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Myomo Inc generates 0.77x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Myomo Inc is currently not profitable relative to its asset base.
Myomo Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.49 | 2.10 | 5.03 |
| Quick Ratio | 2.10 | 1.62 | 4.79 |
| Cash Ratio | 1.36 | 0.95 | 0.00 |
| Working Capital | $13.75 Million | $ 7.71 Million | $ 11.58 Million |
Myomo Inc - Advanced Valuation Insights
This section examines the relationship between Myomo Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.16 |
| Latest Market Cap to Assets Ratio | 0.47 |
| Asset Growth Rate (YoY) | 189.7% |
| Total Assets | $42.24 Million |
| Market Capitalization | $19.94 Million USD |
Valuation Analysis
Below Book Valuation: The market values Myomo Inc's assets below their book value (0.47 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Myomo Inc's assets grew by 189.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Myomo Inc (2014–2024)
The table below shows the annual total assets of Myomo Inc from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $42.24 Million | +189.71% |
| 2023-12-31 | $14.58 Million | +43.49% |
| 2022-12-31 | $10.16 Million | -49.43% |
| 2021-12-31 | $20.10 Million | +36.61% |
| 2020-12-31 | $14.71 Million | +122.92% |
| 2019-12-31 | $6.60 Million | -20.32% |
| 2018-12-31 | $8.28 Million | -40.74% |
| 2017-12-31 | $13.97 Million | +742.75% |
| 2016-12-31 | $1.66 Million | +9.90% |
| 2015-12-31 | $1.51 Million | -50.45% |
| 2014-12-31 | $3.05 Million | -- |